A citation-based method for searching scientific literature

Rebecca DerSimonian, Nan Laird. Contemp Clin Trials 2015
Times Cited: 983







List of co-cited articles
96 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Measuring inconsistency in meta-analyses.
Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, Douglas G Altman. BMJ 2003
33

Bias in meta-analysis detected by a simple, graphical test.
M Egger, G Davey Smith, M Schneider, C Minder. BMJ 1997
24

Quantifying heterogeneity in a meta-analysis.
Julian P T Higgins, Simon G Thompson. Stat Med 2002
20

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Julian P T Higgins, Douglas G Altman, Peter C Gøtzsche, Peter Jüni, David Moher, Andrew D Oxman, Jelena Savovic, Kenneth F Schulz, Laura Weeks, Jonathan A C Sterne. BMJ 2011
16



Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. PLoS Med 2009
13

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.
D F Stroup, J A Berlin, S C Morton, I Olkin, G D Williamson, D Rennie, D Moher, B J Becker, T A Sipe, S B Thacker. JAMA 2000
12

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.
David Moher, Larissa Shamseer, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. Syst Rev 2015
11

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Ann Intern Med 2009
7

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. BMJ 2009
7


Meta-analysis in clinical trials.
R DerSimonian, N Laird. Control Clin Trials 1986
5

How to perform a meta-analysis with R: a practical tutorial.
Sara Balduzzi, Gerta Rücker, Guido Schwarzer. Evid Based Ment Health 2019
538
5

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
5


RoB 2: a revised tool for assessing risk of bias in randomised trials.
Jonathan A C Sterne, Jelena Savović, Matthew J Page, Roy G Elbers, Natalie S Blencowe, Isabelle Boutron, Christopher J Cates, Hung-Yuan Cheng, Mark S Corbett, Sandra M Eldridge,[...]. BMJ 2019
5

Assessing the quality of reports of randomized clinical trials: is blinding necessary?
A R Jadad, R A Moore, D Carroll, C Jenkinson, D J Reynolds, D J Gavaghan, H J McQuay. Control Clin Trials 1996
4

Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.
Beverley J Shea, Jeremy M Grimshaw, George A Wells, Maarten Boers, Neil Andersson, Candyce Hamel, Ashley C Porter, Peter Tugwell, David Moher, Lex M Bouter. BMC Med Res Methodol 2007
4

Meta-analysis of prevalence.
Jan J Barendregt, Suhail A Doi, Yong Yi Lee, Rosana E Norman, Theo Vos. J Epidemiol Community Health 2013
826
4

Estimating the mean and variance from the median, range, and the size of a sample.
Stela Pudar Hozo, Benjamin Djulbegovic, Iztok Hozo. BMC Med Res Methodol 2005
4

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. BMJ 2009
4

Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
Miranda Cumpston, Tianjing Li, Matthew J Page, Jacqueline Chandler, Vivian A Welch, Julian Pt Higgins, James Thomas. Cochrane Database Syst Rev 2019
4


The interpretation of random-effects meta-analysis in decision models.
A E Ades, G Lu, J P T Higgins. Med Decis Making 2005
496
3

A re-evaluation of random-effects meta-analysis.
Julian P T Higgins, Simon G Thompson, David J Spiegelhalter. J R Stat Soc Ser A Stat Soc 2009
3

GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
Gordon H Guyatt, Andrew D Oxman, Gunn E Vist, Regina Kunz, Yngve Falck-Ytter, Pablo Alonso-Coello, Holger J Schünemann. BMJ 2008
3



A basic introduction to fixed-effect and random-effects models for meta-analysis.
Michael Borenstein, Larry V Hedges, Julian P T Higgins, Hannah R Rothstein. Res Synth Methods 2010
3

Assessing heterogeneity in meta-analysis: Q statistic or I2 index?
Tania B Huedo-Medina, Julio Sánchez-Meca, Fulgencio Marín-Martínez, Juan Botella. Psychol Methods 2006
3

Rayyan-a web and mobile app for systematic reviews.
Mourad Ouzzani, Hossam Hammady, Zbys Fedorowicz, Ahmed Elmagarmid. Syst Rev 2016
3

Plea for routinely presenting prediction intervals in meta-analysis.
Joanna IntHout, John P A Ioannidis, Maroeska M Rovers, Jelle J Goeman. BMJ Open 2016
412
2


GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.
Gordon Guyatt, Andrew D Oxman, Elie A Akl, Regina Kunz, Gunn Vist, Jan Brozek, Susan Norris, Yngve Falck-Ytter, Paul Glasziou, Hans DeBeer,[...]. J Clin Epidemiol 2011
2

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration.
Alessandro Liberati, Douglas G Altman, Jennifer Tetzlaff, Cynthia Mulrow, Peter C Gøtzsche, John P A Ioannidis, Mike Clarke, P J Devereaux, Jos Kleijnen, David Moher. PLoS Med 2009
2

AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both.
Beverley J Shea, Barnaby C Reeves, George Wells, Micere Thuku, Candyce Hamel, Julian Moran, David Moher, Peter Tugwell, Vivian Welch, Elizabeth Kristjansson,[...]. BMJ 2017
2

Mental health problems and social media exposure during COVID-19 outbreak.
Junling Gao, Pinpin Zheng, Yingnan Jia, Hao Chen, Yimeng Mao, Suhong Chen, Yi Wang, Hua Fu, Junming Dai. PLoS One 2020
686
2

Clinical features, laboratory characteristics, and outcomes of patients hospitalized with coronavirus disease 2019 (COVID-19): Early report from the United States.
Saurabh Aggarwal, Nelson Garcia-Telles, Gaurav Aggarwal, Carl Lavie, Giuseppe Lippi, Brandon Michael Henry. Diagnosis (Berl) 2020
185
2

Factors Associated With Mental Health Outcomes Among Health Care Workers Exposed to Coronavirus Disease 2019.
Jianbo Lai, Simeng Ma, Ying Wang, Zhongxiang Cai, Jianbo Hu, Ning Wei, Jiang Wu, Hui Du, Tingting Chen, Ruiting Li,[...]. JAMA Netw Open 2020
2

The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations.
Brian Hutton, Georgia Salanti, Deborah M Caldwell, Anna Chaimani, Christopher H Schmid, Chris Cameron, John P A Ioannidis, Sharon Straus, Kristian Thorlund, Jeroen P Jansen,[...]. Ann Intern Med 2015
2

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.
Larissa Shamseer, David Moher, Mike Clarke, Davina Ghersi, Alessandro Liberati, Mark Petticrew, Paul Shekelle, Lesley A Stewart. BMJ 2015
2

Bayesian methods in meta-analysis and evidence synthesis.
A J Sutton, K R Abrams. Stat Methods Med Res 2001
368
2


Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation.
Nikolaos A Patsopoulos, Evangelos Evangelou, John P A Ioannidis. Int J Epidemiol 2008
500
2

Assessing bias in studies of prognostic factors.
Jill A Hayden, Danielle A van der Windt, Jennifer L Cartwright, Pierre Côté, Claire Bombardier. Ann Intern Med 2013
2

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
David Moher, Alessandro Liberati, Jennifer Tetzlaff, Douglas G Altman. Int J Surg 2010
2

Trial Sequential Analysis in systematic reviews with meta-analysis.
Jørn Wetterslev, Janus Christian Jakobsen, Christian Gluud. BMC Med Res Methodol 2017
348
2

Interrater reliability: the kappa statistic.
Mary L McHugh. Biochem Med (Zagreb) 2012
2



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.